Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Prima Andalan Mandiri Tbk. (MCOL) Price & Performance

UBC Medical Indonesia Tbk.Trade
Prima Andalan Mandiri Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Prima Andalan Mandiri Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Prima Andalan Mandiri Tbk. trades at Rp3,750 (market cap 13.26T, 1K 24h volume). The key difference: Prima Andalan Mandiri Tbk. is far larger — about 20.9× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 1K). Which is the better fit depends on your goals.

LABSMCOL
Market Cap
635.95B13.26T
Volume
843K1K
Lot
8.43K10
Turnover
137.6M3.75M
Average Price
163.223,745
Value
137.6M3.75M
Indicative Equilibrium Price
1653,750
Indicative Equilibrium Volume
2465

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MCOL
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Prima Andalan Mandiri Tbk.

PT Prima Andalan Mandiri Tbk (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Nurul Hidajati Handoko, S.H., No. 1 dated June 1, 2005. The Company started commercial activities in 2011.

Read more on MCOL